Citius Pharmaceuticals Inc (CTXR)

Citius Pharmaceuticals Inc (CTXR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $14.6M; returns 1 day +8.8%, 1 week -12.3%, 1 year -76.5%.

Citius Pharmaceuticals, Inc. (CTXR) is a biopharmaceutical company transitioning from a clinical-stage to a commercial-stage entity. Its primary business model is centered on the development and commercialization of first-in-class critical care products. As of late 2025, the company has begun generating its first significant product revenue following the FDA approval and U.S.

Groups CTXR belongs to

CTXR financial model: income statement, cash flow and balance sheet